Cargando…
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission
AIMS: Genetic and pharmacological inhibition of mitochondrial fission induced by acute myocardial ischaemia/reperfusion injury (IRI) has been shown to reduce myocardial infarct size. The clinically used anti-hypertensive and heart failure medication, hydralazine, is known to have anti-oxidant and an...
Autores principales: | Kalkhoran, Siavash Beikoghli, Kriston-Vizi, Janos, Hernandez-Resendiz, Sauri, Crespo-Avilan, Gustavo E, Rosdah, Ayeshah A, Lees, Jarmon G, Costa, Joana Rodrigues Simoes Da, Ling, Naomi X Y, Holien, Jessica K, Samangouei, Parisa, Chinda, Kroekkiat, Yap, En Ping, Riquelme, Jaime A, Ketteler, Robin, Yellon, Derek M, Lim, Shiang Y, Hausenloy, Derek J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752357/ https://www.ncbi.nlm.nih.gov/pubmed/33386841 http://dx.doi.org/10.1093/cvr/cvaa343 |
Ejemplares similares
-
Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It!
por: Ong, Sang-Bing, et al.
Publicado: (2017) -
Assessing the effects of mitofusin 2 deficiency in the adult heart using 3D electron tomography
por: Beikoghli Kalkhoran, Siavash, et al.
Publicado: (2017) -
The RISK pathway leading to mitochondria and cardioprotection: how everything started
por: Yellon, Derek M., et al.
Publicado: (2023) -
Targeting mitochondrial shape: at the heart of cardioprotection
por: Hernandez-Resendiz, Sauri, et al.
Publicado: (2023) -
Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease
por: Ong, Sang-Bing, et al.
Publicado: (2015)